R. Michael Carruthers - 23 May 2022 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Chief Financial Officer
Signature
/s/ John R. Moore Attorney-in-Fact for R. Michael Carruthers
Issuer symbol
EWTX
Transactions as of
23 May 2022
Net transactions value
$0
Form type
4
Filing time
25 May 2022, 18:11:28 UTC
Previous filing
03 May 2022
Next filing
22 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Options Exercise $6,390 +9,000 +300% $0.7100* 12,000 23 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Options Exercise $6,390 -9,000 -4.2% $0.7100* 207,122 23 May 2022 Common Stock 9,000 $0.7100 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,562 shares purchased on November 15, 2021 and 1,438 shares purchased on May 15, 2022 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
F2 1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.